Medicine and Dentistry
Mycosis
100%
Antifungal Therapy
100%
Antifungal Agent
75%
Amphotericin B
50%
Infection
25%
Neoplasm
25%
Immunosuppressive Treatment
25%
Antiinfective Agent
25%
Bioavailability
25%
Thermal Burn
25%
Human Immunodeficiency Virus Infection
25%
Parasitic Disease
25%
Visceral Leishmaniasis
25%
Nephrotoxicity
25%
Neutropenia
25%
Immunocompromised Patient
25%
Illness
25%
Pancreatitis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antifungal Therapy
100%
Mycosis
100%
Antifungal Agent
75%
Amphotericin B
50%
Bioavailability
25%
Chemotherapy
25%
Burn
25%
Nephrotoxicity
25%
Parasitosis
25%
Antiinfective Agent
25%
Infection
25%
Neoplasm
25%
Human Immunodeficiency Virus Infection
25%
Visceral Leishmaniasis
25%
Immunocompromised Patient
25%
Pancreatitis
25%
Neutropenia
25%
Keyphrases
Marketed Formulations
100%
Amphotericin B
66%
New Antifungal
33%
Parasitic Diseases
33%
Antifungal Drugs
33%
Antifungal Compounds
33%
Neoplastic Disease
33%
Opportunistic Fungal Infection
33%
Kidney Toxicity
33%
Broad-spectrum Antimicrobials
33%
Pancreatitis
33%
Neutropenia
33%